Rchr
J-GLOBAL ID:201001036231883669   Update date: Oct. 27, 2023

Kiniwa Yukiko

キニワ ユキコ | Kiniwa Yukiko
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.shinshu-u.ac.jp/faculty/medicine/chair/i-hifu/index.html
Research theme for competitive and other funds  (13):
  • - 2012 メラノーマにおける制御性T細胞誘導へのケモカインと腫瘍浸潤マクロファージの関与
  • - 2008 ヒトメラノーマにおける腫瘍拒絶能と制御性T細胞による腫瘍エスケープ機構の解明
  • 循環腫瘍細胞を用いたメラノーマに対するプレシジョン医療の開発
  • development of precision medicine for melanoma
  • metabolism in cancer cell and metastasis
Show all
Papers (68):
  • Fujisawa Y, Namikawa K, Yoshino K, Kiniwa Y, Ito T, Kato H, Matsushita S, Hoashi T, Nakamura Y, Yoshikawa S, Miyagawa T, Asai J, Matsuya T, Fukushima S, Kato J, Takenouchi T, Uchi H, Masuzawa M, Yanagi T, Maekawa T. Combined use of nivolumab and ipilimumab among Japanese melanoma patients: Multi-center, retrospective study of 111 cases. Br J Dermatol. 2023. 223-250
  • Inozume T, Namikawa K, Kato H, Yoshikawa S, Kiniwa Y, Yoshino K, Mizuhashi S, Ito T, Takenouchi T, Matsushita S, Fujisawa Y, Matsuzawa T, Sugihara S, Asai J, Kitagawa H, Maekawa T, Isei T, Yasuda M, Yamazaki N, Uhara H, Nakamura Y. Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study. J Dermatol Sci. 2023. 19. 26
  • Namikawa K, Ito T, Yoshikawa S, Yoshino K, Kiniwa Y, Ohe S, Isei T, Takenouchi T, Kato H, Mizuhashi S, Fukushima S, Yamamoto Y, Inozume T, Fujisawa Y, Yamasaki O, Nakamura Y, Asai J, Maekawa T, Funakoshi T, Matsushita S, Nakano E, Oashi K, Kato J, Uhara H, Miyagawa T, Uchi H, Hatta N, Tsutsui K, Maeda T, Matsuya T, Yanagisawa H, Muto I, Okumura M, Ogata D, Yamazaki N. Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study). 2023
  • Kamimura, Anna, Nakamura, Yasuhiro, Takenouchi, Tatsuya, Matsushita, Shigeto, Omodaka, Toshikazu, Yamamura, Kentaro, Uchi, Hiroshi, Yoshikawa, Shusuke, Yanagisawa, Hiroto, Ito, Takamichi, et al. Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN). JOURNAL OF DERMATOLOGY. 2022. 49. 9. 837-844
  • Kato, Junji, Namikawa, Kenjiro, Uehara, Jiro, Nomura, Motoo, Nakamura, Yasuhiro, Uhara, Hisashi, Uchi, Hiroshi, Yoshikawa, Shusuke, Kiniwa, Yukiko, Nakamura, Yoshiyuki, et al. Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study. BRITISH JOURNAL OF DERMATOLOGY. 2022. 187. 4. 594-596
more...
Books (3):
  • 皮膚の悪性腫瘍 (皮膚科臨床アセット 17)
    中山書店 (総編集:古江増隆,専門編集:山﨑直也) 2014
  • 1冊でわかる皮膚がん
    文光堂(斎田俊明、宮地良樹、清水宏、編) 2011
  • EBMがん化学療法・分子標的治療法2011-2012
    中外医学社(西條長宏 監修) 2010
Professional career (1):
  • Ph.D. (Shinshu University)
Work history (6):
  • 2018/10/01 - associate professor
  • 2011/07/01 - 2018/09/30 Shinshu University Shinshu University Hospital
  • 2006/06/01 - 2011/06/30 Shinshu University School of Medicine
  • 2003/04/03 - 2006/05/25 Post doctoral associate, Center for Cell and Gene Therapy, Baylor College of Medicine
  • 2000/11 - 2003/03 Shinshu University School of Medicine
Show all
Committee career (5):
  • 2022/06 - 2024/06 日本皮膚科学会 雑誌委員
  • 2018/01 - 2024/01 日本皮膚科学会 代議員
  • 2021 - 日本皮膚悪性腫瘍学会 事務局長
  • 2017 - 2020 日本皮膚悪性腫瘍学会 雑誌委員会・編集幹事
  • 2013 - 日本研究皮膚科学会 評議員
Association Membership(s) (8):
Society for Melanoma Research ,  日本皮膚免疫アレルギー学会 ,  日本アレルギー学会 ,  日本皮膚悪性腫瘍学会 ,  日本研究皮膚科学会 ,  日本がん免疫学会 ,  日本免疫学会 ,  日本皮膚科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page